The present invention relates to a pharmaceutical composition comprising at least one Toll-like receptor ligand and at leastOne peptide that relates to the use of such a pharmaceutical preparation and also relating to a method of vaccination.
The present invention relates to a pharmaceutical composition comprising at least one Toll-like receptor ligand and at least one peptide. The invention relates to the use of such a pharmaceutical preparation and also relates to a method of vaccination.